{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:56:52Z","timestamp":1761897412038,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2014\/27198-8"],"award-info":[{"award-number":["2014\/27198-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11011-020-00640-0","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T06:02:52Z","timestamp":1604642572000},"page":"265-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fabry disease: GLA deletion alters a canonical splice site in a family with neuropsychiatric manifestations"],"prefix":"10.1007","volume":"36","author":[{"given":"Patr\u00edcia","family":"Varela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerson","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renan Paulo","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-632X","authenticated-orcid":false,"given":"Jo\u00e3o Bosco","family":"Pesquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"key":"640_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13353-018-0444-7","volume":"59","author":"A Abramowicz","year":"2018","unstructured":"Abramowicz A, Gos M (2018) Splicing mutations in human genetic disorders: examples, detection, and confirmation. J Appl Genet 59:253\u2013268. https:\/\/doi.org\/10.1007\/s13353-018-0444-7","journal-title":"J Appl Genet"},{"issue":"5","key":"640_CR2","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2016090964","volume":"28","author":"M Arends","year":"2017","unstructured":"Arends M, Wanner C, Hughes D, Mehta A, Oder D, Watkinson OT et al (2017) Characterization of classical and nonclassical Fabry disease: a multicenter study. J Am Soc Nephrol 28(5):1631\u20131164. https:\/\/doi.org\/10.1681\/ASN.2016090964","journal-title":"J Am Soc Nephrol"},{"key":"640_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pscychresns.2019.04.012","volume":"288","author":"DM Barch","year":"2019","unstructured":"Barch DM, Tillmanb R, Kelly D, Whalen D, Gilbert K, Luby JL (2019) Hippocampal volume and depression among young children. Psychiatry Res Neuroimaging 288:21\u201328. https:\/\/doi.org\/10.1016\/j.pscychresns.2019.04.012","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"2","key":"640_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10545-013-9643-x","volume":"37","author":"FE Bolsover","year":"2014","unstructured":"Bolsover FE, Murphy E, Cipolotti L, Werring DJ, Lachmann RH (2014) Cognitive dysfunction and depression in Fabry disease: a systematic review. J Inherit Metab Dis 37(2):177\u2013187. https:\/\/doi.org\/10.1007\/s10545-013-9643-x","journal-title":"J Inherit Metab Dis"},{"key":"640_CR5","doi-asserted-by":"publisher","first-page":"146546","DOI":"10.1016\/j.brainres.2019.146546","volume":"1727","author":"F Chen","year":"2019","unstructured":"Chen F, Bertelsen AB, Holm IE, Nyengaard JR, Rosenberg R, Dorph-Petersen KA (2019) Hippocampal volume and cell number in depression, schizophrenia, and suicide subjects. Brain Res 1727:146546. https:\/\/doi.org\/10.1016\/j.brainres.2019.146546","journal-title":"Brain Res"},{"issue":"6","key":"640_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10545-007-0708-6","volume":"30","author":"AL Cole","year":"2007","unstructured":"Cole AL, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH (2007) Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis 30(6):943\u2013951. https:\/\/doi.org\/10.1007\/s10545-007-0708-6","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"640_CR7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10545-009-1254-1","volume":"32","author":"TW Crosbie","year":"2009","unstructured":"Crosbie TW, Packman W, Packman S (2009) Psychological aspects of patients with Fabry disease. J Inherit Metab Dis 32(6):745\u2013753. https:\/\/doi.org\/10.1007\/s10545-009-1254-1","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"640_CR8","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet FO, Hamroun D, Lalande M, Collod-Beround G, Claustre M, Beround C (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37(9):e67. https:\/\/doi.org\/10.1093\/nar\/gkp215","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"640_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ana.410310410","volume":"31","author":"GA deVeber","year":"1992","unstructured":"deVeber GA, Schwarting GA, Kolodny EH, Kowall NW (1992) Fabry disease: immunocytochemical characterization of neuronal involvement. Ann Neurol 31(4):409\u2013415. https:\/\/doi.org\/10.1002\/ana.410310410","journal-title":"Ann Neurol"},{"issue":"2","key":"640_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10545-011-9390-9","volume":"35","author":"A Fellgiebel","year":"2012","unstructured":"Fellgiebel A, Wolf DO, Kolodny E, M\u00fcller MJ (2012) Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease. J Inherit Metab Dis 35(2):363\u2013367. https:\/\/doi.org\/10.1007\/s10545-011-9390-9","journal-title":"J Inherit Metab Dis"},{"key":"640_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbadis.2009.11.003","volume":"1802","author":"C Filoni","year":"2010","unstructured":"Filoni C, Caciotti A, Carraresi L, Cavicchi C, Parini R, Antuzzi D et al (2010) Functional studies of new GLA gene mutations leading to conformational Fabry disease. Biochim Biophys Acta 1802:247\u2013252. https:\/\/doi.org\/10.1016\/j.bbadis.2009.11.003","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"640_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000322794","volume":"44","author":"S Gairing","year":"2011","unstructured":"Gairing S, Wiest R, Metzler S, Theodoridou A, Hoff P (2011) Fabry's disease and psychosis: causality or coincidence? Psychopathology. 44(3):201\u2013204. https:\/\/doi.org\/10.1159\/000322794","journal-title":"Psychopathology."},{"key":"640_CR13","unstructured":"Hamilton B (2006) State of depression in America. Depression and Bipolar Support Alliance (DBSA). Available online at: https:\/\/www.dbsalliance.org\/pdfs\/wpsearchable.pdf. Accessed 04\/11\/20"},{"issue":"5","key":"640_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s00415-004-0364-9","volume":"251","author":"MJ Hilz","year":"2004","unstructured":"Hilz MJ, Kolodny EH, Brys M, Stemper B, Haendl T, Marthol H (2004) Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease. J Neurol 251(5):564\u2013570. https:\/\/doi.org\/10.1007\/s00415-004-0364-9","journal-title":"J Neurol"},{"key":"640_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.gene.2017.10.064","volume":"641","author":"P Juchniewicz","year":"2018","unstructured":"Juchniewicz P, Kloska A, Tylki-Szyma\u0144ska A, Jak\u00f3bkiewicz-Banecka J, W\u0119grzyn G et al (2018) Female Fabry disease patients and X-chromosome inactivation. Gene 641:259\u2013264. https:\/\/doi.org\/10.1016\/j.gene.2017.10.064","journal-title":"Gene"},{"key":"640_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pscychresns.2017.03.014","volume":"263","author":"SV Kalmady","year":"2017","unstructured":"Kalmady SV, Shivakumar V, Arasappa R, Subramaniam A, Gautham S, Venkatasubramanian G et al (2017) Clinical correlates of hippocampus volume and shape in antipsychotic-na\u00efve schizophrenia. Psychiatry Res Neuroimaging 263:93\u2013102. https:\/\/doi.org\/10.1016\/j.pscychresns.2017.03.014","journal-title":"Psychiatry Res Neuroimaging"},{"key":"640_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581:434\u2013443. https:\/\/doi.org\/10.1038\/s41586-020-2308-7","journal-title":"Nature"},{"issue":"1","key":"640_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13023-020-1307-y","volume":"15","author":"S K\u00f6rver","year":"2020","unstructured":"K\u00f6rver S, Geurtsen GJ, Hollak CEM, van Schaik IN, Longo MGF, Lima MR et al (2020) Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and pain. Orphanet Journal of Rare Diseases 15(1):28. https:\/\/doi.org\/10.1186\/s13023-020-1307-y","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"5","key":"640_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10897-013-9613-3","volume":"22","author":"DA Laney","year":"2013","unstructured":"Laney DA, Bennett RL, Clarke V, Fox A, Hopkin RJ, Johnson J et al (2013) Fabry disease practice guidelines: recommendations of the National Society of genetic counselors. J Genet Couns 22(5):555\u2013564. https:\/\/doi.org\/10.1007\/s10897-013-9613-3","journal-title":"J Genet Couns"},{"issue":"9","key":"640_CR20","doi-asserted-by":"publisher","first-page":"e0137603","DOI":"10.1371\/journal.pone.0137603","volume":"10","author":"IM Lelieveld","year":"2015","unstructured":"Lelieveld IM, B\u00f6ttcher A, Hennermann JB, Beck M, Fellgiebel A (2015) Eight-year follow-up of neuropsychiatric symptoms and brain structural changes in Fabry disease. PLoS One 10(9):e0137603. https:\/\/doi.org\/10.1371\/journal.pone.0137603","journal-title":"PLoS One"},{"issue":"3","key":"640_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/archpsyc.1973.04200030090014","volume":"29","author":"EH Liston","year":"1973","unstructured":"Liston EH, Levine MD, Philippart M (1973) Psychosis in Fabry disease and treatment with phenoxybenzamine. Arch Gen Psychiatry 29(3):402\u2013403. https:\/\/doi.org\/10.1001\/archpsyc.1973.04200030090014","journal-title":"Arch Gen Psychiatry"},{"issue":"14","key":"640_CR22","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1212\/WNL.0000000000001450","volume":"84","author":"M L\u00f6hle","year":"2015","unstructured":"L\u00f6hle M, Hughes D, Milligan A, Richfield L, Reichmann H, Mehta A et al (2015) Clinical prodromes of neurodegeneration in Anderson-Fabry disease. Neurology 84(14):1454\u20131464. https:\/\/doi.org\/10.1212\/WNL.0000000000001450","journal-title":"Neurology"},{"issue":"8","key":"640_CR23","doi-asserted-by":"publisher","first-page":"e1003632","DOI":"10.1371\/journal.pgen.1003632","volume":"9","author":"J Lukas","year":"2013","unstructured":"Lukas J, Giese AK, Markoff A, Grittner U, Kolodny E, Mascher H et al (2013) Functional characterization of alpha-galactosidase a mutation as a basis for a new classification system in fabry disease. PLoS Genet 9(8):e1003632. https:\/\/doi.org\/10.1371\/journal.pgen.1003632","journal-title":"PLoS Genet"},{"key":"640_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1741-7015-2-13","volume":"2","author":"J McGrath","year":"2004","unstructured":"McGrath J, Saha S, Welham J et al (2004) A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2:13. https:\/\/doi.org\/10.1186\/1741-7015-2-13","journal-title":"BMC Med"},{"issue":"5","key":"640_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/jnc.14577","volume":"148","author":"MC Mckenna","year":"2019","unstructured":"Mckenna MC, Schuck PF, Ferreira GC (2019) Fundamentals of CNS energy metabolism and alterations in lysosomal storage diseases. J Neurochem 148(5):590\u2013599. https:\/\/doi.org\/10.1111\/jnc.14577","journal-title":"J Neurochem"},{"issue":"4","key":"640_CR26","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/jmri.20162","volume":"20","author":"DF Moore","year":"2004","unstructured":"Moore DF, Ye F, Brennan ML, Gupta S, Barshop BA, Steiner RD, Rhead WJ, Brady RO et al (2004) Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: an arterial spin tagging study. J Magn Reson Imaging 20(4):674\u2013683. https:\/\/doi.org\/10.1002\/jmri.20162","journal-title":"J Magn Reson Imaging"},{"issue":"1\u20132","key":"640_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jns.2007.01.053","volume":"257","author":"DF Moore","year":"2007","unstructured":"Moore DF, Kaneski CR, Askari H, Schiffmann R (2007) The cerebral vasculopathy of Fabry disease. J Neurol Sci 257(1\u20132):258\u2013263. https:\/\/doi.org\/10.1016\/j.jns.2007.01.053","journal-title":"J Neurol Sci"},{"key":"640_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1746-1596-5-65","volume":"5","author":"KB Muller","year":"2010","unstructured":"Muller KB, Rodrigues MDB, Pereira VG, Martins AM, D\u2019Almeida V (2010) Reference values for lysosomal enzyme activities using dried blood spots samples \u2013 a Brazilian experience. Diagn Pathol 5:65. https:\/\/doi.org\/10.1186\/1746-1596-5-65","journal-title":"Diagn Pathol"},{"issue":"7","key":"640_CR29","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/humu.23220","volume":"38","author":"MS Naslavsky","year":"2017","unstructured":"Naslavsky MS, Yamamoto GL, de Almeida TF, Ezquina ASM, Sunaga DY, Pho N et al (2017) Exomic variants of an elderly cohort of Brazilians in the ABraOM database. Hum Mutat 38(7):751\u2013763. https:\/\/doi.org\/10.1002\/humu.23220","journal-title":"Hum Mutat"},{"key":"640_CR30","doi-asserted-by":"publisher","unstructured":"Nelson MP, Tse TE, O'Quinn DB, Percival SM, Jaimes EA, Warnock DG, et. al. (2014). Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice. Acta Neuropathol Commun. 2:20. doi: https:\/\/doi.org\/10.1186\/2051-5960-2-20","DOI":"10.1186\/2051-5960-2-20"},{"issue":"5","key":"640_CR31","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1440-1789.2008.00883.x","volume":"28","author":"R Okeda","year":"2008","unstructured":"Okeda R, Nisihara M (2008) An autopsy case of Fabry disease with neuropathological investigation of the pathogenesis of associated dementia. Neuropathology. 28(5):532\u2013540. https:\/\/doi.org\/10.1111\/j.1440-1789.2008.00883.x","journal-title":"Neuropathology."},{"key":"640_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/BF00223869","volume":"95","author":"T Okumiya","year":"1995","unstructured":"Okumiya T, Ishii S, Kase R, Kamei S, Sakuraba H, Suzuki Y (1995) Alpha-galactosidase gene mutations in Fabry disease: heterogeneous expressions of mutant enzyme proteins. Hum Genet 95:557\u2013561. https:\/\/doi.org\/10.1007\/BF00223869","journal-title":"Hum Genet"},{"key":"640_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/TACG.S146022","volume":"12","author":"JP Oliveira","year":"2019","unstructured":"Oliveira JP, Ferreira S (2019) Multiple phenotypic domains of Fabry disease and their relevance for establishing genotype\u2013 phenotype correlations. Appl Clin Genet 12:35\u201350. https:\/\/doi.org\/10.2147\/TACG.S146022","journal-title":"Appl Clin Genet"},{"key":"640_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/hmg\/3.3.503","volume":"3","author":"JK Ploos van Amstel","year":"1994","unstructured":"Ploos van Amstel JK, Jansen RP, de Jong JG, Hamel BC, Wevers RA (1994) Six novel mutations in the alpha-galactosidase a gene in families with Fabry disease. Hum Mol Genet 3:503\u2013505. https:\/\/doi.org\/10.1093\/hmg\/3.3.503","journal-title":"Hum Mol Genet"},{"issue":"4","key":"640_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1590\/2237-6089-2017-0130","volume":"40","author":"MAO Santos","year":"2018","unstructured":"Santos MAO, Bezerra LS, Carvalho A, Brainer-Lima AM (2018) Global hippocampal atrophy in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Trends Psychiatry Psychother 40(4):369\u2013378. https:\/\/doi.org\/10.1590\/2237-6089-2017-0130","journal-title":"Trends Psychiatry Psychother"},{"issue":"23","key":"640_CR36","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.2169\/internalmedicine.54.4719","volume":"54","author":"J Sawada","year":"2015","unstructured":"Sawada J, Katayama T, Kano K, Asanome A, Takahashi K, Saito T et al (2015) A sporadic case of Fabry disease involving repeated fever, psychiatric symptoms, headache, and ischemic stroke in an adult Japanese woman. Intern Med 54(23):3069\u20133074. https:\/\/doi.org\/10.2169\/internalmedicine.54.4719","journal-title":"Intern Med"},{"key":"640_CR37","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/humu.9327","volume":"25","author":"E Schafer","year":"2005","unstructured":"Schafer E, Baron K, Widmer U, Deegan P, Neumann HP, Sunder-Plassmann G et al (2005) Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease. Hum Mutat 25:412. https:\/\/doi.org\/10.1002\/humu.9327","journal-title":"Hum Mutat"},{"issue":"2","key":"640_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1468-1331.2010.03155.x","volume":"18","author":"I Schermuly","year":"2011","unstructured":"Schermuly I, M\u00fcller MJ, M\u00fcller KM, Albrecht J, Keller I, Yakushev I et al (2011) Neuropsychiatric symptoms and brain structural alterations in Fabry disease. Eur J Neurol 18(2):347\u2013353. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03155.x","journal-title":"Eur J Neurol"},{"issue":"4","key":"640_CR39","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10545-010-9133-3","volume":"33","author":"P Segal","year":"2010","unstructured":"Segal P, Kohn Y, Pollak Y, Altarescu G, Galili-Weisstub E, Raas-Rothschild A (2010) Psychiatric and cognitive profile in Anderson-Fabry patients: a preliminary study. J Inherit Metab Dis 33(4):429\u2013436. https:\/\/doi.org\/10.1007\/s10545-010-9133-3","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"640_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/humu.20144","volume":"25","author":"J Shabbeer","year":"2005","unstructured":"Shabbeer J, Robinson M, Desnick RJ (2005) Detection of alpha galactosidase a mutations causing Fabry disease by denaturing highperformance liquid chromatography. Hum Mutat 25(3):299\u2013305. https:\/\/doi.org\/10.1002\/humu.20144","journal-title":"Hum Mutat"},{"issue":"3","key":"640_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.pnpbp.2006.11.017","volume":"31","author":"YC Shen","year":"2007","unstructured":"Shen YC, Haw-Ming L, Lin CC, Chen CH (2007) Psychosis in a patient with Fabry's disease and treatment with aripiprazole. Prog Neuro-Psychopharmacol Biol Psychiatry 31(3):779\u2013780. https:\/\/doi.org\/10.1016\/j.pnpbp.2006.11.017","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"640_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/gb4150","volume":"15","author":"T Sterne-Weiler","year":"2014","unstructured":"Sterne-Weiler T, Sanford JR (2014) Exon identity crisis: disease-causing mutations that disrupt the splicing code. Genome Biol 15(1):201. https:\/\/doi.org\/10.1186\/gb4150","journal-title":"Genome Biol"},{"issue":"6","key":"640_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/jhg.2012.32","volume":"57","author":"LT Tura\u00e7a","year":"2012","unstructured":"Tura\u00e7a LT, Pessoa JG, Motta FL, Mu\u00f1oz Rojas MV, M\u00fcller KB et al (2012) New mutations in the GLA gene in Brazilian families with Fabry disease. J Hum Genet 57(6):347\u2013351. https:\/\/doi.org\/10.1038\/jhg.2012.32","journal-title":"J Hum Genet"},{"key":"640_CR44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3389\/fgene.2019.00783","volume":"10","author":"P Varela","year":"2019","unstructured":"Varela P, Caldas MM, Pesquero JB (2019) Novel GLA mutation promotes intron inclusion leading to Fabry disease. Front Genet 10:783. https:\/\/doi.org\/10.3389\/fgene.2019.00783","journal-title":"Front Genet"},{"issue":"3","key":"640_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000503998","volume":"144","author":"P Varela","year":"2020","unstructured":"Varela P, Mastroianni-Kirsztajn G, Ferrer H, Aranda C, Wallbach K, Ferreira da Mata G et al (2020a) Functional characterization and pharmacological evaluation of a novel GLA missense mutation found in a severely affected Fabry disease family. Nephron. 144(3):147\u2013155. https:\/\/doi.org\/10.1159\/000503998","journal-title":"Nephron."},{"issue":"1","key":"640_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13023-019-1274-3","volume":"15","author":"P Varela","year":"2020","unstructured":"Varela P, Mastroianni-Kirsztajn G, Motta FL, Martin RP, Tura\u00e7a LT, Ferrer HLF et al (2020b) Correlation between GLA variants and alpha-galactosidase a profile in dried blood spot: an observational study in Brazilian patients. Orphanet J Rare Dis 15(1):30. https:\/\/doi.org\/10.1186\/s13023-019-1274-3","journal-title":"Orphanet J Rare Dis"},{"key":"640_CR47","doi-asserted-by":"publisher","unstructured":"Wang, R.Y., Lelis, A., Mirocha, J., Wilcox, W.R. (2007). Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med;9(1):34\u201345. doi: https:\/\/doi.org\/10.1097\/gim.0b013e31802d8321","DOI":"10.1097\/gim.0b013e31802d8321"},{"key":"640_CR48","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/mp.2016.72","volume":"22","author":"T Wise","year":"2017","unstructured":"Wise T, Radua J, Via E, Cardoner N, Abe O, Adams TM et al (2017) Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis. Mol Psychiatry 22:1455\u20131463. https:\/\/doi.org\/10.1038\/mp.2016.72","journal-title":"Mol Psychiatry"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00640-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-020-00640-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00640-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T07:24:00Z","timestamp":1610954640000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-020-00640-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["640"],"URL":"https:\/\/doi.org\/10.1007\/s11011-020-00640-0","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"type":"print","value":"0885-7490"},{"type":"electronic","value":"1573-7365"}],"subject":[],"published":{"date-parts":[[2020,11,6]]},"assertion":[{"value":"12 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest and confirm independence from the sponsors. The sponsors have not influenced the content of the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Research Ethics Committee of the Federal University of S\u00e3o Paulo, Brazil approved this protocol (0585\/07 and 0354\/18). All procedures were followed in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013<i>.<\/i> All subjects involved in this study were older than 16\u00a0year at the time of the study. All four patients gave written informed consent agreeing to participate in the study and for the publication of their clinical cases<b>.<\/b> The consent was in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and patient consent statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}